Highlight Therapeutics Sl. Spain
Research
Date range: 1 December 2020 - 30 November 2021
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Highlight Therapeutics Sl. published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
1 | 0.01 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 1 | 0.01 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.20 |
Collaboration
Date range: 1 December 2020 - 30 November 2021
International vs. domestic collaboration by Share
- 40.34% Domestic
- 59.66% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Highlight Therapeutics Sl. by Share (6 total)
-
Highlight Therapeutics Sl. and Bellvitge Biomedical Research Institute (IDIBELL)
(0.29)
-
Highlight Therapeutics Sl. and Catalan Health Institute (ICS)
(0.15)
-
Highlight Therapeutics Sl. and University of Barcelona (UB)
(0.08)
-
Highlight Therapeutics Sl. and Catalan Institute of Oncology (ICO)
(0.08)
-
Highlight Therapeutics Sl. and Spanish National Cancer Research Centre (CNIO)
(0.06)
-
Highlight Therapeutics Sl. and University of Valencia Science Park
(0.03)
Top 10 international collaborators with Highlight Therapeutics Sl. by Share (23 total)
-
Highlight Therapeutics Sl. and Université Libre de Bruxelles (ULB)
(0.40)
-
Highlight Therapeutics Sl. and Catholic University of Leuven (KU Leuven)
(0.04)
-
Highlight Therapeutics Sl. and International Center for Infectiology Research (CIRI)
(0.04)
-
Highlight Therapeutics Sl. and American University of Beirut (AUB)
(0.04)
-
Highlight Therapeutics Sl. and Melbourne Health
(0.03)
-
Highlight Therapeutics Sl. and Peter MacCallum Cancer Centre (Peter Mac)
(0.03)
-
Highlight Therapeutics Sl. and Walter and Eliza Hall Institute of Medical Research (WEHI)
(0.03)
-
Highlight Therapeutics Sl. and Memorial Sloan Kettering Cancer Center (MSKCC)
(0.03)
-
Highlight Therapeutics Sl. and University of Lyon
(0.03)
-
Highlight Therapeutics Sl. and Institute Gustave-Roussy (IGR)
(0.03)

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.